D. Bhamidipati

Human type II arginase: sequence analysis and tissue-specific expression.

S. Morris, D. Kepka‐Lenhart, D. Bhamidipati, 1997, Gene.

Phenotypic heterogeneity associated with the splicing mutation in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

E. Hoffman, S. Witchel, J. Cohen, 1996, The Journal of clinical endocrinology and metabolism.

PARP inhibitors: enhancing efficacy through rational combinations

T. Yap, Natalie Y L Ngoi, D. Bhamidipati, 2023, British Journal of Cancer.

Cracking KRASG12C across all solid tumors: the new kid on the block for tissue-agnostic precision medicine

V. Subbiah, D. Bhamidipati, 2023, ESMO open.

Impact of tissue-agnostic approvals for patients with gastrointestinal malignancies.

V. Subbiah, Deepak Bhamidipati, D. Bhamidipati, 2022, Trends in cancer.

Tumor-agnostic drug development in dMMR/MSI-H solid tumors.

V. Subbiah, Deepak Bhamidipati, D. Bhamidipati, 2023, Trends in cancer.